Never change your prescribed dose without talking to your medical team first
While novel therapies, such as those derived from nanotechnology or personalized medicine, hold great potential for improving treatment outcomes, their high development costs and complexity can limit accessibility for patients
Tambin redujeron su ndice de masa corporal y la masa grasa, especialmente en adultos con sobrepeso u obesidad
thus, despite the therapeutic potential, the effect and mechanism of endogenous nesfatin is still poorly understood
This marks the first time a regulatory authority has formally acknowledged the link, following multiple studies suggesting an increased risk of NAION among type-2 diabetes patients taking semaglutide
The 2024 semaglutide phase 2 RCT and the Weill Cornell cohort data are the most rigorous current evidence showing bone loss - but reasonable endocrinologists interpret even those findings with appropriate uncertainty about generalizability